Title:
MEDICAMENT COMBINATIONS OF NIFEDIPINE AND CERIVASTATIN
Document Type and Number:
WIPO Patent Application WO2001021158
Kind Code:
A3
Abstract:
The invention relates to a combination of at least one dihydropyridine compound (component A) and an HMG-CoA reductase inhibitor (component B), to the use of this combination for treating cardiovascular diseases, to medicaments containing this combination and to the production of the same.
Inventors:
WAGENER GILBERT (DE)
ZIEGLER REINER (DE)
LAMMENS ROBERT FRANK (DE)
ZIEGLER REINER (DE)
LAMMENS ROBERT FRANK (DE)
Application Number:
PCT/EP2000/008980
Publication Date:
October 11, 2001
Filing Date:
September 14, 2000
Export Citation:
Assignee:
BAYER AG (DE)
WAGENER GILBERT (DE)
ZIEGLER REINER (DE)
LAMMENS ROBERT FRANK (DE)
WAGENER GILBERT (DE)
ZIEGLER REINER (DE)
LAMMENS ROBERT FRANK (DE)
International Classes:
A61K45/06; (IPC1-7): A61K31/22; A61K31/44; A61P9/00
Domestic Patent References:
| WO1999011260A1 | 1999-03-11 | |||
| WO2000045817A1 | 2000-08-10 |
Other References:
KUBITSCHECK J.: "Koronare Herzkrankheit (KHK): Der Calciumantagonist Nifedipin (Adalat) ist zur Prophylaxe atherosklerotisher Plaques geignet", BAYER-SYMPOSIUM. FROM SURROGATE ENDPOINTS TO CLINICAL OUTCOMES: INTACT, ENCORE AND ACTION, ADALAT SATELLITE SYMPOSIUM, 27 April 1998 (1998-04-27), Rio de Janeiro, Brasil, pages 1 - 4, XP002163612, Retrieved from the Internet [retrieved on 20010320]
DIEHL M.: "Les résultats d'une nouvelle étude présentés à l'occasion de l'assamblée annuelle de l'American Heart Association montrent qu'Adalat améliore considérablement la fonction endothéliale", CNW, November 2000 (2000-11-01), pages 1 - 2, XP002163611, Retrieved from the Internet [retrieved on 20010320]
DIEHL M.: "Les résultats d'une nouvelle étude présentés à l'occasion de l'assamblée annuelle de l'American Heart Association montrent qu'Adalat améliore considérablement la fonction endothéliale", CNW, November 2000 (2000-11-01), pages 1 - 2, XP002163611, Retrieved from the Internet
Download PDF: